Michael Patrick Gray

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (13)

James Chong

Professor of Cardiovascular Medicine

University of Sydney

AUSTRALIA

View details

Robert Frantz

Professor of Medicine

Mayo Clinic

UNITED STATES

View details

John O'Sullivan

Professor of Cardiometabolic Medicine

University of Sydney

AUSTRALIA

View details

Richard Kronmal

UNITED STATES

View details

Elijah Genetzakis

University of Sydney

AUSTRALIA

View details

Gemma A Figtree

University of Sydney

AUSTRALIA

View details

Yemima Berman

Head of Department

AUSTRALIA

View details

Jodie Ingles

AUSTRALIA

View details

Jean Yang

Professor

University of Sydney

AUSTRALIA

View details

Rebecca R. Vanderpool

Assistant Professor

Ohio State University

UNITED STATES

View details

Kara Bischoff

Associate Professor

University of California, San Francisco

UNITED STATES

View details

Michael Kassiou

University of Sydney

AUSTRALIA

View details

Peter Meikle

Head

Baker Heart and Diabetes Institute

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Patrick Gray

Research Interests

Explore related searches

Contact this professor

Articles (13)

Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease

Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet

Genetic testing in cardiovascular disease

Primary prevention of cardiovascular disease in women

Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease

Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial.

Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort

Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association Registry

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors

High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix® Technology

Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease

EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: Data from PHAR

Protocol for the Stimulating β 3 -Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: A double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease

Collaborators (13)

James Chong

Robert Frantz

John O'Sullivan

Richard Kronmal

Elijah Genetzakis

Gemma A Figtree

Yemima Berman

Jodie Ingles

Jean Yang

Rebecca R. Vanderpool

Kara Bischoff

Michael Kassiou

Peter Meikle

Make your next move.